2024-12-25 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**1. Performance vs. S&P 500 (VOO):**

Eli Lilly and Co. (LLY) is a pharmaceutical company that discovers, develops, manufactures, and markets pharmaceutical products.  The cumulative return of LLY is significantly higher than the S&P 500 (VOO) over the analyzed period. The difference in cumulative returns between LLY and VOO is 458.6%, indicating substantial outperformance.  The relative divergence of 73.3% suggests LLY's performance is in the upper quartile of its historical performance range relative to the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** $795.67
* **5-day Moving Average:** $776.39
* **20-day Moving Average:** $793.92
* **60-day Moving Average:** $831.15

The current price is slightly above the 20-day moving average, suggesting recent momentum. However, it's below the 60-day moving average, indicating a potential short-term pullback from recent highs.

**3. Technical Indicators and Expected Return:**

* **RSI:** 36.59  (Suggests the stock may be oversold, but further analysis is needed.)
* **PPO:** 0.20 (Positive value indicates bullish momentum, but the magnitude is relatively low.)
* **20-Day Relative Divergence:** +2.2 (Indicates recent short-term upward movement.)
* **Expected Return (2+ years):** 554.6% (This is a significant expected outperformance relative to the S&P 500, and should be viewed with caution.  This high number likely reflects historical outperformance and may not be sustainable.)  Given the current price near recent highs and an oversold RSI, this high projected return needs to be interpreted carefully.  A significant correction could occur before continued growth can be expected.

**4. Recent Earnings Analysis:**

The provided earnings data shows significant volatility in both EPS and revenue.

* **Revenue:** Revenue shows some fluctuation but generally demonstrates growth between quarters.
* **EPS:** EPS shows very large swings, with a considerable negative EPS reported in 2023-11-02 and 2024-10-30.  Without further context or comparison to analyst expectations, it is impossible to assess whether these values represent beats or misses.  The significant volatility in EPS warrants further investigation.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remained relatively stable, fluctuating around $11B, excluding the quarter ending 2024-03-31. Profit margins consistently remain high, around 80%.
* **Capital and Profitability:** Equity shows growth, with some fluctuations. ROE is highly volatile, reaching extremely high values in some quarters (over 20%) and negative values in others. This suggests significant shifts in the company's operational performance and financial leverage.

**6. News and Recent Issues:**

* **No recent earning news (within the last two days) is provided.**  The analysis requires information on the most recent earnings announcement to assess market reaction and analyst opinions.  The lack of this information is a significant limitation to this analysis.
* **Missing Market Outlook and Analyst Opinions:** Information on market outlook and analyst opinions is needed to gain a holistic view of the company's current position and future prospects.

**7. Overall Analysis:**

LLY has shown significant outperformance against the S&P 500 in the past, but the provided data also highlights substantial volatility in both earnings and financial metrics. The high projected return should be viewed with caution given the high levels of volatility. The stock shows some signs of potential short-term pullback, with the current price below the 60-day moving average. Technical indicators (RSI) suggest potential oversold conditions but this is inconclusive without supporting information.  Further analysis is needed, including a comparison of reported earnings against analyst expectations and examination of the company's recent news and future guidance.  Crucially, more information is required on recent market sentiment and analyst opinions.


**8. Disclaimer:** This analysis is based solely on the limited data provided.  It does not constitute financial advice.  Investing in the stock market involves risk, and you should conduct thorough research and consult with a financial advisor before making any investment decisions.
